You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 8,399,445


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,399,445 protect, and when does it expire?

Patent 8,399,445 protects ACETADOTE and is included in one NDA.

This patent has thirteen patent family members in ten countries.

Summary for Patent: 8,399,445
Title:Acetylcysteine composition and uses thereof
Abstract: This invention relates to novel acetylcysteine compositions in solution, comprising acetylcysteine and which are substantially free of metal chelating agents, such as EDTA. Further, this invention relates to methods of making and using the acetylcysteine compositions. The present compositions and methods are designed to improve patient tolerance and compliance, while at the same time maintaining the stability of the pharmaceutical formulation. The compositions and methods of this invention are useful in the treatment of acetaminophen overdose, acute liver failure, various cancers, methacrylonitrile poisoning, reperfusion injury during cardio bypass surgery, and radiocontrast-induced nephropathy, and can also be used as a mucolytic agent.
Inventor(s): Pavliv; Leo (Cary, NC)
Assignee: Cumberland Pharmaceuticals, Inc. (Nashville, TN)
Application Number:13/406,175
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent 8,399,445

Introduction

United States Patent 8,399,445, titled "Acetylcysteine Composition and Uses Thereof," is a significant patent that outlines novel compositions and methods related to acetylcysteine, a compound used in various medical treatments. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Patent

The patent, granted to the inventors, describes acetylcysteine compositions that are substantially free of metal chelating agents. These compositions are particularly useful in the treatment of acetaminophen overdose, acute liver failure, and various cancers[4].

Scope of the Patent

The scope of the patent is defined by its claims, which are the legally binding descriptions of the invention. Here are the key aspects:

Composition

The patent claims compositions that include acetylcysteine and are substantially free of metal chelating agents. This is crucial because the presence of chelating agents can affect the stability and efficacy of acetylcysteine[4].

Uses

The patent outlines several uses for these compositions, including:

  • Treatment of acetaminophen overdose
  • Treatment of acute liver failure
  • Treatment of various cancers
  • Other medical applications where acetylcysteine is beneficial[4].

Claims Analysis

Independent Claims

The independent claims are the broadest claims in the patent and define the core of the invention. For example, Claim 1 might describe the composition of acetylcysteine substantially free of metal chelating agents, while Claim 2 might describe the method of using this composition for treating acetaminophen overdose[4].

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations. For instance, a dependent claim might specify the concentration of acetylcysteine in the composition or the method of administration (e.g., intravenous injection)[4].

Prior Art and Novelty

To be granted, a patent must be novel and non-obvious over the prior art. The patent office ensures that the claimed invention is not anticipated by existing patents or publications. In this case, the novelty lies in the specific composition of acetylcysteine without metal chelating agents, which was not previously disclosed in the prior art[4].

Patent Landscape

International Patent Offices

The patent landscape for acetylcysteine compositions is global. To determine if similar patents exist abroad, one would need to search international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Related Patents

Searching related patents can reveal other inventions in the same field. For example, using the USPTO's Patent Public Search tool or the Global Dossier service can help identify patent families and related applications filed at participating IP offices[1].

Economic and Research Implications

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents, including those related to pharmaceutical compositions. This dataset can be used to analyze trends and scope measurements of patents like US 8,399,445[3].

Market Impact

The patent's claims and scope can significantly impact the market by:

  • Protecting the inventors' rights to their novel composition.
  • Influencing the development of similar treatments by other companies.
  • Affecting the pricing and availability of acetylcysteine-based treatments[3].

Legal Considerations

Derivation and Obviousness

The patent must not be derived from prior communications or be obvious over the existing prior art. For instance, the communication of an idea that makes the claimed invention obvious is not enough to show derivation, as highlighted in legal precedents[5].

Office Actions and Litigation

The patent's validity can be challenged through office actions or litigation. Tools like the Global Dossier and the Common Citation Document (CCD) help in identifying potential issues by consolidating citation data from multiple patent offices[1].

Practical Applications

Medical Treatments

The compositions described in the patent are crucial for treating specific medical conditions. For example, the treatment of acetaminophen overdose and acute liver failure relies on the stability and efficacy of acetylcysteine, which is ensured by the absence of metal chelating agents[4].

Pharmaceutical Development

Pharmaceutical companies can use this patent as a reference for developing new formulations of acetylcysteine. The patent's claims provide a roadmap for what is considered novel and non-obvious in this field[4].

Key Takeaways

  • Novel Composition: The patent describes acetylcysteine compositions substantially free of metal chelating agents.
  • Medical Uses: The compositions are used for treating acetaminophen overdose, acute liver failure, and various cancers.
  • Global Patent Landscape: Similar patents can be searched through international patent databases.
  • Economic Impact: The patent influences the market by protecting the inventors' rights and affecting the development of similar treatments.
  • Legal Considerations: The patent must be novel and non-obvious, and its validity can be challenged through office actions or litigation.

FAQs

Q: What is the main claim of United States Patent 8,399,445?

A: The main claim is for acetylcysteine compositions that are substantially free of metal chelating agents.

Q: What are the primary uses of the compositions described in the patent?

A: The primary uses include the treatment of acetaminophen overdose, acute liver failure, and various cancers.

Q: How can one determine if similar patents exist internationally?

A: One can search international patent databases such as those provided by the EPO, JPO, and WIPO.

Q: What is the significance of the absence of metal chelating agents in the composition?

A: The absence of metal chelating agents ensures the stability and efficacy of acetylcysteine in medical treatments.

Q: How does the patent impact the pharmaceutical market?

A: The patent protects the inventors' rights, influences the development of similar treatments, and affects the pricing and availability of acetylcysteine-based treatments.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. US-8399445-B2 - Acetylcysteine Composition and Uses Thereof: https://portal.unifiedpatents.com/patents/patent/US-8399445-B2
  3. Patent Claims Research Dataset - USPTO: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. US8399445B2 - Acetylcysteine composition and uses thereof - Google Patents: https://patents.google.com/patent/US8399445B2/en
  5. Communication of an Idea that Makes the Claimed Invention Obvious is Not Enough to Show Derivation: https://www.harnessip.com/blog/2017/01/27/communication-of-an-idea-that-makes-the-claimed-invention-obvious-is-not-enough-to-show-derivation/

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,399,445

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Cumberland Pharms ACETADOTE acetylcysteine INJECTABLE;INTRAVENOUS 021539-001 Jan 23, 2004 AP RX Yes Yes ⤷  Subscribe ⤷  Subscribe METHOD OF TREATING ACETAMINOPHEN OVERDOSE WITH ACETYLCYSTEINE SOLUTIONS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,399,445

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2006282030 ⤷  Subscribe
Canada 2619441 ⤷  Subscribe
China 101242824 ⤷  Subscribe
China 102266316 ⤷  Subscribe
European Patent Office 1928449 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.